Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus


Esophageal cancer is increasing in frequency in the United States faster than any other cancer. Barrett's esophagus, an otherwise benign complication of esophageal reflux, affects approximately three million Americans and precedes almost all cases of esophageal cancer. If detected as high-grade dysplasia (HGD), most esophageal cancers can be prevented. Standard-of-care screening for dysplasia uses visual endoscopy and a prescribed pattern of biopsy. This procedure, in which a tiny fraction of the affected tissue is selected for pathological examination, has a low probability of detection because dysplasia is highly focal and visually indistinguishable. We developed a system called endoscopic polarized scanning spectroscopy (EPSS), which performs rapid optical scanning and multispectral imaging of the entire esophageal surface and provides diagnoses in near real time. By detecting and mapping suspicious sites, guided biopsy of invisible, precancerous dysplasia becomes practicable. Here we report the development of EPSS and its application in several clinical cases, one of which merits special consideration.

DOI: 10.1038/nm.2138
Citations per Year

450 Citations

Semantic Scholar estimates that this publication has 450 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Qiu2010MultispectralSD, title={Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus}, author={Le F. Qiu and Douglas K. Pleskow and Ram Chuttani and Edward Vitkin and Jan E Leyden and Nuri Ozden and Sara Itani and Lianyu Guo and Alana Sacks and Jeffrey D Goldsmith and Mark D Modell and Eugene B. Hanlon and Irving Itzkan and Lev T . Perelman}, journal={Nature Medicine}, year={2010}, volume={16}, pages={603-606} }